Concepedia

Thomas Lundbäck

TL

Statistics

Publications

56

Citations

4.6K

H-Index

31

Active since

1994

Affiliations

Karolinska Institutet(Current)

Science for Life Laboratory

Uppsala University

AstraZeneca (Sweden)

KTH Royal Institute of Technology

Thomas Lundbäck is an author at Karolinska Institutet specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1994–2024

56

Publications

56

The cellular thermal shift assay for evaluating drug target interactions in cells

Rozbeh Jafari, Helena Almqvist, Hanna Axelsson et al. · Nature Protocols · 2014 · 1.5K citations

Medicine, Cell Biology, Pharmacology +13

MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool

Helge Gad, Tobias Koolmeister, Ann‐Sofie Jemth et al. · Nature · 2014 · 529 citations

Medicine, Cancer Biology, Oncology +4

Solution structure and DNA-binding properties of a thermostable protein from the archaeon Sulfolobus solfataricus

Herbert Baumann, Stefan Knapp, Thomas Lundbäck et al. · Nature Structural Biology · 1994 · 167 citations

Life Sciences, Biochemistry, Molecular Biology +11

CETSA screening identifies known and novel thymidylate synthase inhibitors and slow intracellular activation of 5-fluorouracil

Helena Almqvist, Hanna Axelsson, Rozbeh Jafari et al. · Nature Communications · 2016 · 164 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies

Nikolas Herold, Sean G. Rudd, Linda Ljungblad et al. · Nature Medicine · 2017 · 142 citations

Medicine, Hematology, Pharmacology +10

1–5 of 56